Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Wellbutrin Immediate Release Tablets, Wellbutrin SR (Bupropion Hydrochloride) Sustained Release Tablets & XL Extended Release Tablets
Company: GlaxoSmithKline
Application No.: 018644s027s028, 020358s031s032 & 021515s006s007
Approval Date: 05/27/2004


Date created:  June 22, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.